Purpose of rotundic acid to preparation of medicines for treating pneumonia

A technology for the use of iron hollylic acid, which is applied in the field of preparing drugs for the treatment of pneumonia, can solve the problems such as the treatment of bacterial pneumonia that has not been reported, and achieve the effect of improving the survival rate

Active Publication Date: 2020-05-12
GUANGXI XINHAI PHARM TECH CO LTD
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Ferric acid (RA) is one of the main chemical components of Holly Kejiubing. Studies have found that RA has pharmacological effects such as antibacterial, anti-tumor, anti-oxidation, and immune regulation, but there is no report on its treatment of bacterial pneumonia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Purpose of rotundic acid to preparation of medicines for treating pneumonia
  • Purpose of rotundic acid to preparation of medicines for treating pneumonia
  • Purpose of rotundic acid to preparation of medicines for treating pneumonia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] The present invention will be further described in detail below in conjunction with the accompanying drawings, so that those skilled in the art can implement it with reference to the description.

[0025] It should be understood that terms such as "having", "comprising" and "including" as used herein do not entail the presence or addition of one or more other elements or combinations thereof.

[0026] It should be noted that the experimental methods described in the following embodiments, unless otherwise specified, are conventional methods, and the reagents and materials, unless otherwise specified, can be obtained from commercial sources.

[0027] 1 material

[0028] 1.1 Experimental animals

[0029] SPF grade healthy BALB / C mice, weighing 20-22g, 7-8 weeks old, male, were purchased from Hunan Slack Jingda Experimental Animal Co., Ltd. All experimental animals were raised in a controlled environment, room temperature 18-24°C, The humidity was 40%-50%. During the exp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a purpose of rotundic acid as an only active component to preparation of medicines for treating pneumonia. The rotundic acid has definite protective effects on a model mouse suffering from pneumonia, and the mechanism of the rotundic acid is possibly relevant to restraining of release of proinflammatory cytokine in lungs.

Description

technical field [0001] The present invention relates to the field of medicine. More specifically, the present invention relates to the use of a kind of ferriopartic acid as the only active ingredient in the preparation of a medicine for treating pneumonia. Background technique [0002] Community Acquired Pneumonia (CAP) refers to the inflammation of the terminal airways, alveoli and pulmonary interstitium, which is caused by pathogenic microorganisms, physical and chemical factors, immune injury, allergies and drugs outside the hospital. Pathogens that cause pneumonia, such as bacteria, fungi, chlamydia, viruses and other microorganisms, among which bacteria are the most common pneumonia. In recent years, the incidence of pneumonia has been increasing. Some scholars have conducted statistics on the mortality rate of pneumonia, which is less than 1% to 5% for outpatients, about 12% for inpatients, and as high as 40% for those admitted to the intensive care unit. Pneumonia ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/56A61P11/00A61P31/04
CPCA61K31/56A61P11/00A61P31/04
Inventor 高红伟李新星苑仁祎坤黄莉婷许琼明杨世林
Owner GUANGXI XINHAI PHARM TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap